Treatment of severe motion sickness with antimotion sickness drug injections.

Abstract

This report concerns the use of intramuscular injections of scopolamine, promethazine, and dramamine to treat severely motion sick individuals participating in parabolic flight experiments. The findings indicate that a majority of individuals received benefit from 50-mg injections of promethazine or 0.5mg-injections of scopolamine. By contrast, 50-mg injections of dramamine and 25-mg injections of promethazine were nonbeneficial. The use of antimotion drug injections for treating space motion sickness is discussed.

• Authors: A Graybiel, J R Lackner
• Journal: Aviation, space, and environmental medicine (Aviat Space Environ Med) Vol. 58 Issue 8 Pg. 773-6 (Aug 1987) ISSN: 0095-6562 [Print] United States
• PMID: 3632537 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• Scopolamine
• Promethazine
• Dimenhydrinate

Topics

• Dimenhydrinate (therapeutic use)
• Humans
• Injections, Intramuscular
• Motion Sickness (drug therapy)
• Promethazine (therapeutic use)
• Scopolamine (therapeutic use)
• Space Flight